SGLT2 inhibitors beyond diabetes: myths, evidence and practical prescribing
An overview of the data behind SGLT2i use in cardiometabolic disease, and tips for their use in day-to-day clinical practice. Attendees will benefit from key insights from the expert panel relating to the use of this important therapy in managing chronic disease in the non-diabetic population with cardio-renal disease.
